ALDH3A1 appeared to have a transient decrease in BE (Figure S4), before a return to healthy levels in EAC, and a previous study confirmed a decrease in ALDH3A1 in EAC by immunostaining,10 suggesting that these changes may not necessarily be linear throughout disease stages, and changes are protein‐specific. This evidence concerns the gene ALDH3A1 and Barrett esophagus.